Have a feature idea you'd love to see implemented?
Let us know!
KOSS Koss Corp
Price (delayed)
$7.37
Market cap
$68.92M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.12
Enterprise value
$66.16M
Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data
Highlights
The gross margin is up by 8% year-on-year and by 4.1% since the previous quarter
Koss's gross profit has increased by 2.5% QoQ
Koss's net income has increased by 41% YoY but it has decreased by 17% from the previous quarter
Koss's EPS has increased by 40% YoY but it has decreased by 20% from the previous quarter
The quick ratio has dropped by 64% year-on-year and by 55% since the previous quarter
KOSS's revenue is down by 8% year-on-year
Key stats
What are the main financial stats of KOSS
Market
Valuations
Earnings
Shares outstanding
9.35M
Market cap
$68.92M
Enterprise value
$66.16M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.22
Price to sales (P/S)
5.67
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.47
Revenue
$12.09M
EBIT
-$1.19M
EBITDA
-$978,100
Free cash flow
$218,035
Per share
Balance sheet
Liquidity
EPS
-$0.12
Free cash flow per share
$0.02
Book value per share
$3.32
Revenue per share
$1.3
TBVPS
$4.09
Total assets
$38.1M
Total liabilities
$7.25M
Debt
$0
Equity
$30.85M
Working capital
$16.97M
Debt to equity
0
Current ratio
8.18
Quick ratio
5.62
Net debt/EBITDA
2.81
Margins
Efficiency
Dividend
EBITDA margin
-8.1%
Gross margin
35.5%
Net margin
-9.2%
Operating margin
-16.9%
Return on assets
-2.9%
Return on equity
-3.6%
Return on invested capital
-3.6%
Return on capital employed
-3.3%
Return on sales
-9.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
KOSS stock price
How has the Koss stock price performed over time
Intraday
5.59%
1 week
5.14%
1 month
-5.75%
1 year
177.07%
YTD
120%
QTD
-0.27%
Financial performance
How have Koss's revenue and profit performed over time
Revenue
$12.09M
Gross profit
$4.29M
Operating income
-$2.04M
Net income
-$1.11M
Gross margin
35.5%
Net margin
-9.2%
Koss's net income has increased by 41% YoY but it has decreased by 17% from the previous quarter
Koss's net margin has increased by 36% YoY but it has decreased by 18% QoQ
The operating income has grown by 29% YoY but it has contracted by 9% from the previous quarter
KOSS's operating margin is up by 23% year-on-year but it is down by 10% since the previous quarter
Growth
What is Koss's growth rate over time
Valuation
What is Koss stock price valuation
P/E
N/A
P/B
2.22
P/S
5.67
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.47
Koss's EPS has increased by 40% YoY but it has decreased by 20% from the previous quarter
KOSS's P/B is 71% above its last 4 quarters average of 1.3 but 18% below its 5-year quarterly average of 2.7
The stock's P/S is 72% above its last 4 quarters average of 3.3 and 58% above its 5-year quarterly average of 3.6
KOSS's revenue is down by 8% year-on-year
Efficiency
How efficient is Koss business performance
KOSS's ROIC is up by 45% YoY but it is down by 16% QoQ
Koss's ROA has increased by 41% YoY but it has decreased by 16% from the previous quarter
Koss's ROS has increased by 41% YoY but it has decreased by 17% from the previous quarter
The company's return on equity rose by 40% YoY but it fell by 20% QoQ
Dividends
What is KOSS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for KOSS.
Financial health
How did Koss financials performed over time
The quick ratio has dropped by 64% year-on-year and by 55% since the previous quarter
The current ratio has plunged by 60% YoY and by 52% from the previous quarter
Koss's debt is 100% lower than its equity
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.